Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma
- PMID: 12110341
- DOI: 10.1016/s1368-8375(01)00104-x
Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma
Abstract
Mitogen-activated protein kinases (MAPKs) consist of major three subfamilies, extracellular-signal regulated kinases (ERK MAPKs), the c-Jun N-terminal kinases/stress activated protein kinases (JNK MAPKs/SAP MAPKs), and p38 MAPKs. ERK MAPKs pathway is one of the most important pathways for cell proliferation. ERK MAPKs are located at downstream of a lot of growth factors (epidermal growth factor (EGF), nerve growth factor (NGF), platelet-derived growth factor (PDGF), etc.), the overexpressions and activation of which are frequently detected on a number of cancers including oral squamous cell carcinoma (OSCC). These data indicate that overexpression and activation of ERK MAPKs play an important role in cancer progression. On the contrary, JNK MAPKs are possible regulators of cell death induced by chemotherapeutic agents. p38 MAPKs are activated by pro-inflammatory cytokines and inflammatory drugs (non-steroidal anti-inflammatory drug), which are known to suppress cancer growth. These findings imply that each MAPKs can be molecular targets for cancer therapy in OSCC and its investigation is very important things in OSCC.
Similar articles
-
Proliferative effects of gamma-amino butyric acid on oral squamous cell carcinoma cells are associated with mitogen-activated protein kinase signaling pathways.Int J Mol Med. 2016 Jul;38(1):305-11. doi: 10.3892/ijmm.2016.2597. Epub 2016 May 19. Int J Mol Med. 2016. PMID: 27222045
-
Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.Cancer Lett. 2015 May 1;360(2):310-8. doi: 10.1016/j.canlet.2015.02.034. Epub 2015 Feb 23. Cancer Lett. 2015. PMID: 25721086
-
Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression.J Am Soc Nephrol. 2003 Mar;14(3):584-92. doi: 10.1097/01.asn.0000050415.97942.2f. J Am Soc Nephrol. 2003. PMID: 12595493
-
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.Science. 2002 Dec 6;298(5600):1911-2. doi: 10.1126/science.1072682. Science. 2002. PMID: 12471242 Review.
-
The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs).Int J Biochem Cell Biol. 2001 Nov;33(11):1047-63. doi: 10.1016/s1357-2725(01)00093-0. Int J Biochem Cell Biol. 2001. PMID: 11551821 Review.
Cited by
-
Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario.Pharmaceutics. 2023 Feb 16;15(2):664. doi: 10.3390/pharmaceutics15020664. Pharmaceutics. 2023. PMID: 36839989 Free PMC article. Review.
-
Inflammation and Invasion in Oral Squamous Cell Carcinoma Cells Exposed to Electronic Cigarette Vapor Extract.Front Oncol. 2022 Jul 22;12:917862. doi: 10.3389/fonc.2022.917862. eCollection 2022. Front Oncol. 2022. PMID: 35936727 Free PMC article.
-
Mitogen-activated protein kinase signaling pathway in oral cancer.Oncol Lett. 2018 Feb;15(2):1379-1388. doi: 10.3892/ol.2017.7491. Epub 2017 Nov 24. Oncol Lett. 2018. PMID: 29434828 Free PMC article.
-
Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway.J Cancer Res Clin Oncol. 2025 Mar 7;151(3):103. doi: 10.1007/s00432-025-06154-5. J Cancer Res Clin Oncol. 2025. PMID: 40055197 Free PMC article.
-
Analysis of activated EGFR signalling pathways and their relation to laminin-5 gamma2 chain expression in oral squamous cell carcinoma (OSCC).Histochem Cell Biol. 2005 Aug;124(2):151-60. doi: 10.1007/s00418-005-0001-4. Epub 2005 Sep 29. Histochem Cell Biol. 2005. PMID: 16052324
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous